Definition/General
Introduction:
Normal urine cytology represents the physiological cellular components found in urine specimens from healthy individuals
It demonstrates the normal exfoliation of urothelial cells from the urinary tract
The specimen shows benign cellular morphology without evidence of malignancy or significant inflammation
Normal findings are essential for establishing baseline cytological criteria for comparison with pathological states.
Origin:
Normal urine contains cells exfoliated from the entire urinary tract including renal pelvis, ureters, bladder, and urethra
The majority of cells originate from the bladder urothelium due to its large surface area
Cells are naturally shed as part of the normal turnover of the urothelial lining
The cellular composition varies with the anatomical site and patient age.
Classification:
Normal urine cytology is classified based on the Paris System for reporting urinary cytology
Category I: Non-diagnostic (inadequate specimen)
Category II: Negative for high-grade urothelial carcinoma (normal findings)
This corresponds to the Bethesda System equivalent of benign/normal findings
The classification emphasizes high-grade lesions as the primary concern.
Epidemiology:
Normal urine cytology is observed in healthy individuals of all age groups
Cellular morphology may vary with age, with younger patients showing more uniform cellular appearance
Post-menopausal women may show hormonal effects on urothelial cells
In India, normal findings constitute 80-85% of routine urine cytology examinations
Age-related changes become more apparent after 60 years.
Clinical Features
Presentation:
Patients with normal urine cytology are typically asymptomatic or have non-specific urinary complaints
May present for routine screening as part of health check-ups
Some patients undergo examination for surveillance after previous urological procedures
Occupational screening in high-risk workers exposed to carcinogens
Follow-up examination for resolved urinary symptoms.
Symptoms:
Normal cytology is associated with absence of significant symptoms
Patients may report occasional mild dysuria without pathological correlation
Some experience urinary frequency due to increased fluid intake before specimen collection
No hematuria or blood-tinged urine
No constitutional symptoms such as weight loss or fatigue.
Risk Factors:
Normal findings are more common in younger age groups (<40 years)
Non-smokers have higher likelihood of normal cytology
Absence of occupational carcinogen exposure
No history of chronic urinary tract infections
Adequate hydration and normal urinary habits
Absence of family history of urological malignancies.
Screening:
Routine screening with urine cytology is recommended for high-risk occupational groups
Annual screening for workers exposed to aromatic amines and dyes
Follow-up screening for patients with history of superficial bladder tumors
Not routinely recommended for general population screening
Targeted screening for patients with unexplained hematuria.
Master Normal Urine Cytology Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
Normal urine specimens appear clear to pale yellow in color with normal specific gravity
The specimen should be fresh (collected within 2-4 hours) for optimal cellular preservation
Volume should be adequate (minimum 50 ml) for cytological examination
No visible blood or clots should be present
The specimen may appear slightly turbid if cellular concentration is high.
Characteristics:
Fresh urine specimens maintain cellular integrity with minimal degenerative changes
The pH should be neutral to slightly acidic (6.0-7.5) for optimal preservation
Specific gravity between 1.010-1.025 indicates adequate concentration
Specimens should be free from bacterial contamination
Crystal formation should be minimal in fresh specimens.
Microscopic Description
Immunohistochemistry
Positive Markers:
Normal urothelial cells express CK7 (cytokeratin 7) diffusely
CK20 shows variable positivity, typically in superficial umbrella cells
Uroplakin II and III are expressed in differentiated urothelial cells
p63 shows nuclear positivity in basal and intermediate cells
GATA3 demonstrates nuclear staining in urothelial cells.
Negative Markers:
Normal urothelial cells are typically negative for CK5/6 (squamous differentiation markers)
p16 shows minimal or negative staining
Ki-67 proliferation index is very low (<5%)
p53 shows wild-type pattern (minimal staining)
CEA (carcinoembryonic antigen) is typically negative.
Diagnostic Utility:
Immunohistochemistry is rarely required for normal urine cytology diagnosis
May be used for research purposes or to establish baseline markers
CK7/CK20 pattern helps confirm urothelial origin when needed
p63 staining can help identify basal cell layer architecture
Markers are more useful for distinguishing reactive from neoplastic changes.
Molecular Subtypes:
Normal urothelium does not require molecular subtyping
Baseline expression patterns include normal FGFR3 and PIK3CA wild-type status
TP53 shows wild-type expression pattern
RB1 (retinoblastoma) pathway is intact
These markers serve as reference standards for comparison with pathological states.
Molecular/Genetic
Genetic Mutations:
Normal urothelial cells maintain wild-type genetic status for common urological cancer genes
FGFR3 mutations are absent in normal specimens
PIK3CA mutations are not present in normal urothelium
TP53 mutations are absent, maintaining normal cell cycle regulation
TERT promoter mutations are not found in normal cells.
Molecular Markers:
Normal specimens show stable microsatellites without instability
Chromosome stability is maintained without aneuploidy
Normal telomerase activity is minimal in differentiated cells
DNA repair mechanisms function normally without defects
Apoptosis pathways remain intact and functional.
Prognostic Significance:
Normal cytology indicates excellent prognosis with no immediate malignant risk
False-negative rate for high-grade lesions is approximately 10-20%
Sensitivity for detecting high-grade urothelial carcinoma is 70-80%
Normal findings have high negative predictive value (>95%)
Long-term surveillance may be needed in high-risk patients.
Differential Diagnosis
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
Urine cytology specimen, [collection method], adequate cellularity
Specimen Adequacy
Adequate: Sufficient number of well-preserved urothelial cells for evaluation
Microscopic Findings
Normal urothelial cells with uniform nuclear morphology and appropriate nuclear-to-cytoplasmic ratio. No high-grade nuclear atypia identified.
Background
Clean background with minimal inflammatory cells. No organisms identified.
Cytological Diagnosis
Negative for high-grade urothelial carcinoma (Paris System Category II)
Comments
Normal cytological findings. Correlation with clinical findings recommended.
Recommendations
Follow-up as clinically indicated. Repeat cytology if symptoms persist.